Oxford Pharmascience Group Share News (OXP)

Oxford Pharmascience To Test Improvements To Technology Platform

Oxford Pharmascience hits stumbling block with OXPzero

(ShareCast News) - Specialty pharmaceutical company Oxford Pharmascience updated the market on progress in its commercialisation efforts for its OXPzero Ibuprofen and OXPzero Naproxen compounds. The AIM-traded firm said the two variants leverage its proprietary OXPzero technology platform, which aim

WINNERS & LOSERS SUMMARY: Man Group Down As CEO Departs For PIMCO

Oxford Pharmascience Seeks Partner For Bitter Pill Masking Platform

WINNERS & LOSERS SUMMARY: Gold, Dollar Exposure Rewarded Post-Brexit

UPDATE: UK Chemicals And Pharmaceuticals Must "Look To Future"

Adams Loss Widens As Tough Markets Hit Carrying Value Of Investments

UK Shareholder Meetings Calendar - Next 7 Days

Oxford Pharmascience Gets Positive Feedback For OXPzero Ibuprofen

Losses widen at Ozford Pharmascience

(ShareCast News) - Oxford Pharmascience's losses widened in 2015, as the specialty pharmaceutical company spent more cash in a bid to move a number of products towards registration. The AIM-traded company's revenues jumped to £749,000, from £705,000 in 2014. Gross profit was down, however, to £158,0

Oxford Pharmascience Loss Widens On Increased Research Spending

Oxford Pharmascience adds Reckitt stalwart to board

(ShareCast News) - Oxford Pharmascience added a big name in the OTC medicines industry to its board on Thursday, announcing the appointment of Anand Sharma as a non-executive director with immediate effect. The AIM-traded medicine redevelopment firm said Sharma had worked in the pharmaceutical and c

Oxford Pharmascience Adds Former Reckitt Director Sharma To Board

Oxford Pharmascience Says Ready For Commercial Partnering Talks

Oxford Pharmascience Completes Proof-Of-Concept For OXPzero Ibuprofen